An Egyptian study by El-Benhawy et al. reported that adipocyte-fatty acid binding protein (A-FABP) is associated with the clinical stage of HNSCC and a higher plasma level of A-FABP is a risk marker for HNC [40]. This evidence concerns the gene FABP4 and head and neck squamous cell carcinoma.